Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

88.21 81.21 48.80 28.46
P/S ratio
8.61 7.38 5.06 3.46
P/FCF ratio
53.31 57.15 37.87 39.72
P/Operating CF
172.83 109.09 129.05 119.35
P/B ratio
15.69 13.20 11.27 7.42
Price to Tangible BV
17.70 14.85 12.93 8.40
EV/Sales
8.72 7.47 5.22 3.59
EV/EBITDA
41.91 35.85 25.17 17.83
EV/Operating CF
41.20 35.53 24.47 21.45
EV/FCF
53.94 57.81 39.08 41.28
Quick Ratio
1.88 1.81 1.49 1.51
Current Ratio
2.87 2.81 2.49 2.48
Net Debt/EBITDA
1.84 1.37 3.15 2.64
Debt/Assets
33.50% 29.75% 31.74% 29.96%
Debt/Equity
0.73 0.63 0.73 0.67
Asset Turnover
0.83 0.86 0.89 0.92
Operating CF/Net income
1.43 1.80 1.25 0.93
Capex/Depreciation
(1.41) (6.12) (1.06) (1.40)
Interest Coverage
7.54 9.75 8.31 9.61
Research and Development Expense of Revenue
10.93% 11.60% 11.78% 10.99%
Selling, General and Administrative Expense of Revenue
44.63% 42.29% 41.64% 43.01%
Intangible Assets out of Total Assets
0.05 0.05 0.06 0.05
Share Based Compensation of Revenue
2.36% 2.59% 2.80% 2.44%
Graham Net Nets
0.01 0.01 0.00 0.01
Graham Number
39.36 41.19 42.44 49.70
Earnings Yield
1.13% 1.23% 2.05% 3.51%
Free Cash Flow Yield
1.88% 1.75% 2.64% 2.52%
Revenue per Share
10.04 11.14 10.88 11.57
Operating CF per Share
1.79 2.61 1.63 1.28
Capex per Share
(0.44) (2.12) (0.40) (0.54)
Free Cash Flow per Share
1.34 0.48 1.23 0.74
Cash per Share
10.76 10.18 6.86 7.72
Shareholders Equity per Share
19.67 21.54 18.61 20.52
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
19.67 21.54 18.61 20.52
Free Cash Flow
94.60 33.90 86.00 51.10
Working Capital
1,211.70 1,233.90 1,022.00 1,104.90
Capital Expenditures
(31.10) (149.40) (27.80) (37.30)
Net Current Asset Value
214.30 238.80 24.90 106.20
EV/EBIT
50.30 42.69 29.88 21.26
Capex to Sales
0.04 0.19 0.04 0.05
Price to Operating Income
49.71 42.20 28.96 20.46
Other line items
Average Receivables
418.90 441.20 473.50 516.60
Average Payables
44.25 47.40 103.70 109.70
Average Inventory
445.60 441.50 451.65 465.85
Average Assets
3,027.35 3,139.05 3,252.25 3,317.15
Average Common Equity
1,251.15 1,363.45 1,316.65 1,442.60

Fold the line items

Columns are period end dates